INGN SEC Filings: 8-K, 10-Q, S-3 & 424B – Inogen

Financials

TYPE

HEADLINE

FILED AT

10-Q

NEWForm 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 9, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 8, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 27, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 8, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Inogen Appoints Andy Reding as President and Chief Executive Officer

Nov 5, 2026

8-K

Inogen Announces Divestiture of U.S. Oxygen Rental Business to Rotech and Increase to Share Repurchase Authorization

Sep 30, 2026

8-K

Inogen Reports Second Quarter 2026 Financial Results and Raises Full-Year Adjusted EBITDA Guidance

Aug 6, 2026

8-K

Inogen Appoints Andy Reding as Chief Operating Officer

Jul 1, 2026

8-K

Inogen, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 11, 2026

8-K

Inogen Announces First Quarter 2026 Financial Results and Reiterates Full-Year Guidance

May 7, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B4

Form 424B4 - Prospectus [Rule 424(b)(4)]

Oct 30, 2014

424B4

Form 424B4 - Prospectus [Rule 424(b)(4)]

Feb 14, 2014

Registrations

TYPE

HEADLINE

FILED AT

S-8

Inogen, Inc. Inducement Award Restricted Stock Unit Agreement

Jul 24, 2026

S-8